Small Extracellular Vesicles from Breast Cancer Cells Induce Cardiotoxicity
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26030945 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jhon Jairo Osorio-Méndez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Master in Biochemistry Program, Department of Physiological Sciences, Faculty of Medicine, Universidad Nacional de Colombia, Bogotá 111321, Colombia. Hauptthemen laut MEDLINE: Extracellular Vesicles, Breast Neoplasms, Doxorubicin, Cardiotoxicity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Nacional de Salud de Colombia, Ministerio de Ciencia, Tecnología e Innovación, National Institute of Health, Colombia.
Abstract (Originalsprache)
Cardiovascular diseases and cancer are leading global causes of morbidity and mortality, necessitating advances in diagnosis and treatment. Doxorubicin (Doxo), a potent chemotherapy drug, causes long-term heart damage due to cardiotoxicity. Small extracellular vesicles (sEVs) carry bioactive molecules—such as proteins, lipids, and nucleic acids—that can modulate gene expression and signaling pathways in recipient cells, including cardiomyocytes. Through the delivery of cytokines, microRNAs, and growth factors, sEVs can influence cell survival, which plays a critical role in the development of cardiotoxicity. This study investigates the role of sEVs derived from breast cancer cells treated or not with Doxo and their potential to induce cardiomyocyte damage, thereby contributing to cardiotoxicity. We isolated sEVs from MCF-7 cells treated or not to Doxo using ultracentrifugation and characterized them through Nanoparticle Tracking Analysis (NTA), Scanning Electron Microscopy (SEM), and Western Blotting (WB) for the markers CD63, CD81, and TSG101. We analyzed cytokine profiles using a Multiplex Assay and Cytokine Membrane Array. We exposed Guinea pig cardiomyocytes to different concentrations of sEVs. We assessed their viability (MTT assay), shortening, reactive oxygen species (ROS–DHE dye) production, mitochondrial membrane potential (JC-1 dye), and calcium dynamics (FLUO-4 dye). We performed statistical analyses, including t-tests, ANOVA, Cohen’s d, and η2 to validate the robustness of the results. Treatment of MCF-7 cells with 0.01 μM Doxorubicin resulted in increased sEVs production, particularly after 48 h of exposure (~1.79 × 108 ± 2.77 × 107 vs. ~5.1 × 107 ± 1.28 × 107 particles/mL, n = 3, p = 0.0019). These sEVs exhibited protein profiles in the 130–25 kDa range and 93–123 nm sizes. They carried cytokines including TNF-α, IL-1β, IL-4, IFN-γ, and IL-10. Exposure of cardiomyocytes to sEVs (0.025 μg/mL to 2.5 μg/mL) from both Doxo-treated and untreated cells significantly reduced cardiomyocyte viability, shortened cell length by up to 20%, increased ROS production, and disrupted calcium homeostasis and mitochondrial membrane potential, indicating severe cellular stress and cardiotoxicity. These findings suggest that Doxo enhances sEVs production from breast cancer cells, which plays a key role in cardiotoxicity through their cytokine cargo. The study highlights the potential of these sEVs as biomarkers for early cardiotoxicity detection and as therapeutic targets to mitigate cardiovascular risks in chemotherapy patients. Future research should focus on understanding the mechanisms by which Doxorubicin-induced sEVs contribute to cardiotoxicity and exploring their diagnostic and therapeutic potential to improve patient safety and outcomes in cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Master in Biochemistry Program, Department of Physiological Sciences, Faculty of Medicine, Universidad Nacional de Colombia, Bogotá 111321, Colombia.
- Molecular Physiology Group, Sub-Direction of Scientific and Technological Research, Direction of Public, Health Research, National Institute of Health, Bogotá 111321, Colombia.
- Department of Physiological Sciences, Faculty of Medicine, Universidad Nacional de Colombia, Bogotá 111321, Colombia.
- Doctorate in Biotechnology Program, Faculty of Sciences, Universidad Nacional de Colombia, Bogotá 111321, Colombia.
ORCID-Profile: Jhon Jairo Osorio-Méndez, Luis Alberto Gómez-Grosso, Gladis Montoya-Ortiz, Susana Novoa-Herrán, Yohana Domínguez-Romero
Förderung
- Instituto Nacional de Salud de Colombia
- Ministerio de Ciencia, Tecnología e Innovación
- National Institute of Health, Colombia
- Ministry of Science, Technology, and Innovation Grant
Zitieren
APA
Osorio-Méndez, J. J., Gómez-Grosso, L. A., Montoya-Ortiz, G., Novoa-Herrán, S., & Domínguez-Romero, Y. (2025). Small Extracellular Vesicles from Breast Cancer Cells Induce Cardiotoxicity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26030945
Vancouver
Osorio-Méndez JJ, Gómez-Grosso LA, Montoya-Ortiz G, Novoa-Herrán S, Domínguez-Romero Y. Small Extracellular Vesicles from Breast Cancer Cells Induce Cardiotoxicity. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26030945
BibTeX
@article{OsorioMndez2025,
author = {Osorio-Méndez, Jhon Jairo and Gómez-Grosso, Luis Alberto and Montoya-Ortiz, Gladis and Novoa-Herrán, Susana and Domínguez-Romero, Yohana},
title = {Small Extracellular Vesicles from Breast Cancer Cells Induce Cardiotoxicity},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26030945}
}
EUVIMED